Pay-for-performance doesn't last

Pay-for-performance programs are apparently not like the Energizer Bunny, according to a new study published in the New England Journal of Medicine. Although pay-for-performance programs can reduce 30-day mortality rates in their initial phases, within a few years the effect wears off and mortality rates often return to their original levels. Factors specific to individual patients and the communities in which they live also contribute to mortality rates outside of the pay-for-performance parameters. Read the full article at FierceHealthcare

 

 

 

 

Suggested Articles

Humana has filed suit against the Trump administration over cost-sharing reduction payments.

The Trump administration has launched a new alternative payment model to provide upfront investments to rural healthcare providers.

Nurx raised an additional $22.5 million in funding in May. Find out why CEO Varsha Rao believes telehealth will not go back to pre-COVID-19 levels.